Pds biotech announces that its covid-19 vaccine consortium received a commitment from the ministry of science, technology and innovation of brazil (mcti) to fund clinical development and commercialization of a versamune®-based covid-19 vaccine with an award of up to approximately us$60 million

Development and commercialization of novel t-cell activating vaccine to be performed in brazil by consortium of pds biotech, farmacore biotechnology and blanver farmoquÍmica development and commercialization of novel t-cell activating vaccine to be performed in brazil by consortium of pds biotech, farmacore biotechnology and blanver farmoquÍmica
PDSB Ratings Summary
PDSB Quant Ranking